IVIG in Acute Ischemic Stroke: A Pilot Study "IVIG/AIS"

Withdrawn

Phase 1 Results N/A

Summary of Purpose

The purpose of the study is to evaluate the ability of IVIG to affect the rate of progression of brain ischemia, as evidenced by neuroimaging. The results of an ongoing epidemiological study indicate that patients with primary immunodeficiency (PID) on IVIG replacement therapy have an overall prevalence of stroke that ... Trial Stopped: difficult recruitment and new black box warning for IVIG

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 November 2013.

1 Mar 2013 14 Jun 2012 1 Aug 2013 1 Sep 2013 1 Nov 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available